ViroMissile, Inc.

LA JOLLA, CA · CIK 0001974798 · Biotech · Private

Intravenously-delivered viral agents that target and kill cancer cells

viromissile.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$150K
2 Form D · Mar 2025
19 months since last filing
Contracts
—
No federal contracts on record
Patents
5
0 granted · 5 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$50,000
Private capital raisedForm D · SEC$100,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2645SYMMETRIC COMPUTING, INC.——
2646Ajaya Bio, Inc.—$150K
2647STEMSAVE INC—$150K
2648ViroMissile, Inc.—$150K
2649Integrated Micro-Chromatography Systems, Inc.—$150K
2650SIDERO BIOSCIENCE, LLC—$145K
2651ORION THERAPEUTICS INC.—$145K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 6 related persons
  • Rolf BenirschkeDirector
  • Mark BertagnolliDirector · Executive Officer
  • Nanhai ChenDirector · Executive Officer
  • Douglas WallDirector
  • Tianyu ZhouDirector
  • Weili ZhouDirector

Patents

USPTO · 0 granted of 5
  • Oncolytic Vaccinia Viruses And Recombinant Viruses And Methods Of Use Thereofapplication
  • Oncolytic Vaccinia Viruses And Recombinant Viruses And Methods Of Use Thereofapplication
  • Oncolytic Vaccinia Viruses And Recombinant Viruses And Methods Of Use Thereofapplication
  • Oncolytic Vaccinia Viruses And Recombinant Viruses And Methods Of Use Thereofapplication
  • Oncolytic Vaccinia Viruses And Recombinant Viruses And Methods Of Use Thereofapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.